Identification functional characterization of brainstem cannabinoid CB2 receptors.
暂无分享,去创建一个
K. Mackie | L. Marnett | Q. Pittman | D. Piomelli | A. Makriyannis | V. Di Marzo | K. Sharkey | P. Kingsley | N. Stella | K. Patel | A. Mouihate | P. Urbani | M. V. Van Sickle | J. Davison | M. Duncan
[1] S. Gaetani,et al. Characterization of the Fatty Acid Amide Hydrolase Inhibitor Cyclohexyl Carbamic Acid 3′-Carbamoyl-biphenyl-3-yl Ester (URB597): Effects on Anandamide and Oleoylethanolamide Deactivation , 2005, Journal of Pharmacology and Experimental Therapeutics.
[2] K. Mackie,et al. A Glial Endogenous Cannabinoid System Is Upregulated in the Brains of Macaques with Simian Immunodeficiency Virus-Induced Encephalitis , 2005, The Journal of Neuroscience.
[3] Michael Davis,et al. Enhancing Cannabinoid Neurotransmission Augments the Extinction of Conditioned Fear , 2005, Neuropsychopharmacology.
[4] Angus C Nairn,et al. Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[5] F. Lenz,et al. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. , 2004, Brain research. Molecular brain research.
[6] A. Barbáchano,et al. Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: An immunohistochemical study , 2004, Synapse.
[7] A. Derbenev,et al. Cannabinoids suppress synaptic input to neurones of the rat dorsal motor nucleus of the vagus nerve , 2004, The Journal of physiology.
[8] L. Petrocellis,et al. The endocannabinoid system and its therapeutic exploitation , 2004, Nature Reviews Drug Discovery.
[9] L. Petrocellis,et al. The endocannabinoid system: a general view and latest additions , 2004, British journal of pharmacology.
[10] Alberto Rábano,et al. Cannabinoid CB2 Receptors and Fatty Acid Amide Hydrolase Are Selectively Overexpressed in Neuritic Plaque-Associated Glia in Alzheimer's Disease Brains , 2003, The Journal of Neuroscience.
[11] S. Gaetani,et al. Anandamide hydrolysis: a new target for anti-anxiety drugs? , 2003, Trends in molecular medicine.
[12] M. Eder,et al. CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity , 2003, Science.
[13] C. Newton,et al. The cannabinoid system and immune modulation , 2003, Journal of leukocyte biology.
[14] B. Cravatt,et al. Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system. , 2003, Current opinion in chemical biology.
[15] T. Freund,et al. Role of endogenous cannabinoids in synaptic signaling. , 2003, Physiological reviews.
[16] I. Matias,et al. Presence and regulation of the endocannabinoid system in human dendritic cells. , 2002, European journal of biochemistry.
[17] T. Freund,et al. Brain monoglyceride lipase participating in endocannabinoid inactivation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[18] K. Mackie,et al. Cloning and molecular characterization of the rat CB2 cannabinoid receptor. , 2002, Biochimica et biophysica acta.
[19] M. Herkenham,et al. International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors , 2002, Pharmacological Reviews.
[20] P J Hornby,et al. Central neurocircuitry associated with emesis. , 2001, The American journal of medicine.
[21] K. Mackie,et al. Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret. , 2001, Gastroenterology.
[22] T. Bisogno,et al. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin‐like activity , 2000, FEBS letters.
[23] T. Bonner,et al. Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. , 2000, European journal of pharmacology.
[24] G. Griffin,et al. Cloning and pharmacological characterization of the rat CB(2) cannabinoid receptor. , 2000, The Journal of pharmacology and experimental therapeutics.
[25] P. Casellas,et al. Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression. , 1996, European journal of biochemistry.
[26] A. Buriani,et al. The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. , 1996, Proceedings of the National Academy of Sciences of the United States of America.